ARAY insider trading
NasdaqGS HealthcareACCURAY INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ACCURAY INC
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Company website: www.accuray.com
ARAY insider activity at a glance
FilingIQ has scored 371 insider transactions for ARAY since Jul 8, 2015. The most recent filing in our index is dated Mar 31, 2026.
Across the full history, 20 open-market purchases
and 99 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ARAY insider trades is 54.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
13F funds holding ARAY
Frequently asked
- How many insider trades does FilingIQ track for ARAY?
- FilingIQ tracks 371 Form 4 insider transactions for ARAY (ACCURAY INC), covering filings from Jul 8, 2015 onwards. 7 of those were filed in the last 90 days.
- Are ARAY insiders net buyers or net sellers?
- Across the full Form 4 history for ARAY, 20 transactions (5%) were open-market purchases and 99 (27%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ARAY insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ARAY in?
- ACCURAY INC (ARAY) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $66.74M.
Methodology & sources
Every ARAY insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.